Is there a shift from cardiovascular to cancer death in lipid-lowering trials? A systematic review and meta-analysis
Main Authors: | Lucy Bolt, Alexandre Speierer, Sylvain Bétrisey, Martina Aeschbacher-Germann, Manuel R. Blum, Baris Gencer, Cinzia Del Giovane, Drahomir Aujseky, Elisavet Moutzouri, Nicolas Rodondi |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado: |
Public Library of Science (PLoS)
2024-01-01
|
Series: | PLoS ONE |
Acceso en liña: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10852259/?tool=EBI |
Títulos similares
-
Is there a shift from cardiovascular to cancer death in lipid-lowering trials? A systematic review and meta-analysis.
por: Lucy Bolt, et al.
Publicado: (2024-01-01) -
Lipid‐Lowering Trials Are Not Representative of Patients Managed in Clinical Practice: A Systematic Review and Meta‐Analysis of Exclusion Criteria
por: Martina Aeschbacher‐Germann, et al.
Publicado: (2023-01-01) -
Lipid‐Lowering Therapy and Risk of Hemorrhagic Stroke: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
por: Sylvain Bétrisey, et al.
Publicado: (2024-02-01) -
Achilles tendon ultrasonography in the clinical screening of familial hypercholesterolaemia – a cross-sectional analysis
por: Maria de Montmollin, et al.
Publicado: (2023-11-01) -
Low Reporting of Cointerventions in Recent Cardiovascular Clinical Trials: A Systematic Review
por: Elisavet Moutzouri, et al.
Publicado: (2020-06-01)